These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4376984)

  • 1. Immunization against Gross malignant lymphoma with mouse cell lines chronically infected with non-oncogenic murine C-type viruses.
    Youn JK; Blanchard MG; Barski G
    Eur J Cancer (1965); 1974 Aug; 10(8):491-6. PubMed ID: 4376984
    [No Abstract]   [Full Text] [Related]  

  • 2. Common cell-surface antigen associated with murine and feline C-type RNA leukemia viruses.
    Yoshiki T; Mellors RC; Hardy WD
    Proc Natl Acad Sci U S A; 1973 Jun; 70(6):1878-82. PubMed ID: 4352660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of skin in gross leukemia. V. Refutation of virus involvement.
    Mariani T; Maruyama Y
    J Natl Cancer Inst; 1974 Dec; 53(6):1661-4. PubMed ID: 4612164
    [No Abstract]   [Full Text] [Related]  

  • 4. An analysis of antigens on the surface of murine leukemia viruses and cells.
    Aoki T
    Bibl Haematol; 1973; 39():307-15. PubMed ID: 4360163
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenic comparison of bovine type C virus with murine and feline leukemia viruses.
    Ferrer JF
    Cancer Res; 1972 Sep; 32(9):1871-7. PubMed ID: 4345040
    [No Abstract]   [Full Text] [Related]  

  • 6. Virus expression and immunoprophylaxis of a murine lymphoma.
    Sekine I; Vredevoe DL; Hays EF
    J Natl Cancer Inst; 1975 Mar; 54(3):727-31. PubMed ID: 164567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of lymphoma cell immunogenicity by infection with nononcogenic virus.
    Eaton MD; Heller JA; Scala AR
    Cancer Res; 1973 Dec; 33(12):3293-8. PubMed ID: 4357358
    [No Abstract]   [Full Text] [Related]  

  • 9. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic expression as a determining factor of tumor growth in Gross' virus lymphoma.
    Ioachim HL; Keller S; Sabbath M; Dorsett B
    Prog Exp Tumor Res; 1974; 19():284-96. PubMed ID: 4373783
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
    Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
    J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.
    Sato H; Boyse EA; Aoki T; Iritani C; Old LJ
    J Exp Med; 1973 Sep; 138(3):593-606. PubMed ID: 4727915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell-related syngeneic skin graft rejection in gross leukemia.
    Mariani T; Maruyama Y; Good RA
    Natl Cancer Inst Monogr; 1972 Dec; 35():309-20. PubMed ID: 4572830
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinction between envelope antigens of murine xenotropic and ecotropic type C viruses by immunoelectron microscopy.
    Oshiro LS; Levy JA; Riggs JL; Lennette EH
    J Gen Virol; 1977 May; 35(2):317-23. PubMed ID: 69013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunizing and interfering action of non-leukemogenic C-type murine virus variants in leukemogenesis.
    Barski G; Youn JK
    Bibl Haematol; 1973; 39():370-6. PubMed ID: 4360168
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent progress in studies of mouse type-C viruses.
    Sarma PS; Gazdar AF
    Curr Top Microbiol Immunol; 1974; (68):1-28. PubMed ID: 4375018
    [No Abstract]   [Full Text] [Related]  

  • 18. Murine erythroblastosis by a novel viral agent.
    Imamura N
    Gan; 1973 Apr; 64(2):121-31. PubMed ID: 4353206
    [No Abstract]   [Full Text] [Related]  

  • 19. Transplantability, immunological unresponsiveness, and loss of cellular antigenicity in gross virus lymphoma.
    Ioachim HL; Keller SE; Dorsett BH
    Bibl Haematol; 1975; (40):301-10. PubMed ID: 51627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological Characterization of C-type retroviruses endogenous to the C57BL/6 mouse and isolated in tumours induced by radiation leukaemia virus (RadLV-Rs).
    Astier T; Guillemain B; Laigret F; Mamoun R; Duplan JF
    J Gen Virol; 1982 Jul; 61 (Pt l)():55-63. PubMed ID: 6181187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.